13F filer · CIK 1697013
Eversept Partners, LP
NEW YORK, NY · filing since Q4 2017 · last filing Aug 14, 2026
Reported value
$1.9B
+$31.2M vs prior
Positions
120
New / sold out
32 / 32
Added / reduced
40 / 41
Turnover
29.6%
buys $565.3M · sells $731.4M
Top-10 weight
45.7%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | ENSIGN GROUP INC | +587,318 | +3978.8% | +$94.1M |
| Added | ENCOMPASS HEALTH CORP | +832,815 | +429.1% | +$84.2M |
| New | CARETRUST REIT INC | +1,072,015 | – | +$43.3M |
| New | UNITEDHEALTH GROUP INC | +51,145 | – | +$21.3M |
| New | COGENT BIOSCIENCES INC | +490,235 | – | +$19.0M |
| New | INSMED INC | +149,209 | – | +$15.9M |
| Added | TENET HEALTHCARE CORP | +84,687 | +287.0% | +$15.8M |
| Added | TRAVERE THERAPEUTICS INC | +256,363 | +47.2% | +$14.6M |
| Added | VIKING THERAPEUTICS INC | +363,812 | +152.2% | +$14.2M |
| New | AMN HEALTHCARE SVCS INC | +428,531 | – | +$13.9M |
62 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | INVESCO QQQ TRPUT | -140,100 | -58.7% | $-103.2M |
| Sold out | SPYSTATE STR SPDR S&P 500 ETF TPUT | -107,000 | -100.0% | $-69.6M |
| Reduced | GSK PLC | -1,303,342 | -73.0% | $-68.3M |
| Reduced | NATERA INC | -208,906 | -54.3% | $-56.7M |
| Sold out | VERTEX PHARMACEUTICALS INCCALL | -90,000 | -100.0% | $-40.2M |
| Sold out | ISHARES TRPUT | -428,800 | -100.0% | $-37.2M |
| Sold out | HEALTHPEAK PROPERTIES INC | -1,981,070 | -100.0% | $-32.5M |
| Sold out | AVANTOR INC | -2,974,287 | -100.0% | $-23.3M |
| Sold out | QIAGEN NV | -545,330 | -100.0% | $-21.8M |
| Reduced | WELLTOWER INC | -93,641 | -51.7% | $-21.3M |
63 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | UNITED THERAPEUTICS CORP DELCOM | 287,668 | $155.9M | 8.09% |
| 2 | ABIVAX SASPONSORED ADS | 913,880 | $121.8M | 6.32% |
| 3 | ENCOMPASS HEALTH CORPCOM | 1,026,919 | $103.8M | 5.38% |
| 4 | ENSIGN GROUP INCCOM | 602,079 | $96.5M | 5.01% |
| 5 | VERA THERAPEUTICS INCCL A | 2,212,770 | $94.9M | 4.93% |
| 6 | INVESCO QQQ TRPUTUNIT SER 1 | 98,600 | $72.6M | 3.77% |
| 7 | CELLDEX THERAPEUTICS INC NEWCOM NEW | 1,785,941 | $66.5M | 3.45% |
| 8 | SYNDAX PHARMACEUTICALS INCCOM | 2,798,210 | $61.2M | 3.17% |
| 9 | BROOKDALE SR LIVING INCCOM | 3,396,470 | $54.6M | 2.84% |
| 10 | IONIS PHARMACEUTICALS INCCOM | 664,684 | $52.7M | 2.73% |
110 more rows. Subscribe for $29/month to see every row, download the data and use the API.